Bottom line
Is JEPAX a good fund? The bottom line
JEPAX is the Class A share class of JPMorgan Equity Premium Income Fund, a managed options & covered-call income mutual fund from J.P. Morgan.
It charges 0.85% — about $85 a year on every $10,000 invested, cheaper than 60% of options & covered-call income funds we track.
It returned +1.8% over one year, +7.7% a year over five years (as of Dec 31, 2025, per its prospectus).
With $5.1 billion in net assets and 127 holdings, its largest position is AbbVie, Inc. (1.7%) and the top 10 make up 15.9% of the portfolio.
This share class carries a front-end sales charge of up to 5.25%; a no-load class or ETF alternative can avoid it.
What to watch
- Front-end sales load up to 5.25%
- 12b-1 marketing fee of 0.25% a year
- High turnover (183% a year) can mean more taxable distributions
Updated Nov 19, 2026
What JEPAX invests in
The Fund seeks current income while maintaining prospects for capital appreciation.
The investment objective of the Fund is to seek current income while maintaining prospects for capital appreciation. The Fund seeks to achieve this objective (1) by creating an actively managed portfolio of equity securities and (2) through equity-linked notes (ELNs), by selling call options with exposure to the S&P 500 Total Return Index (the Index). The resulting Fund, including through both the equity portfolio and the options exposure, is designed to provide investors with total return through capital appreciation and income, while exposing investors to lower volatility than the broad U.S. large cap market and also providing incremental income. The Fund is managed in a way that seeks, under normal circumstances, to provide monthly distributions at a relatively stable level. Under normal circumstances, the Fund invests at least 80% of its Assets in equity securities (80% Policy).…
From the fund's prospectus (filed Oct 27, 2026).
JEPAX performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| JEPAX | +1.8% | +7.7% | — |
| Options & Covered-Call Income median | +7.9% | +8.3% | +6.6% |
Source: Fund prospectus, as of Dec 31, 2025
What JEPAX costs
On a $10,000 investment, JEPAX's 0.85% expense ratio costs about $85 a year. The prospectus estimates $1,519 in total costs over 10 years (assuming 5% annual returns). The median options & covered-call income fund charges 0.99%.
JEPAX top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | AbbVie, Inc. | 1.73% |
| 2 | Howmet Aerospace, Inc. | 1.69% |
| 3 | Johnson & Johnson | 1.66% |
| 4 | Eaton Corp. plc | 1.63% |
| 5 | Trane Technologies plc | 1.61% |
| 6 | Lam Research Corp. | 1.56% |
| 7 | NVIDIA Corp. | 1.52% |
| 8 | Apple, Inc. | 1.52% |
| 9 | Ross Stores, Inc. | 1.51% |
| 10 | Alphabet, Inc. | 1.50% |
Source: SEC Form N-PORT, period ended Jun 30, 2026
The top 10 make up 15.9% of the fund. See all top 25 holdings and asset mix →